These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 33560089

  • 1. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis.
    Barkin JA, Barkin JS.
    Pancreas; 2021 Feb 01; 50(2):176-182. PubMed ID: 33560089
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D.
    Clin Ther; 2010 Jan 01; 32(1):89-103. PubMed ID: 20171415
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
    Thorat V, Reddy N, Bhatia S, Bapaye A, Rajkumar JS, Kini DD, Kalla MM, Ramesh H.
    Aliment Pharmacol Ther; 2012 Sep 01; 36(5):426-36. PubMed ID: 22762290
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP.
    Pancreas; 2016 Sep 01; 45(5):679-86. PubMed ID: 26495784
    [Abstract] [Full Text] [Related]

  • 8. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
    Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP.
    Pancreas; 2006 Aug 01; 33(2):156-62. PubMed ID: 16868481
    [Abstract] [Full Text] [Related]

  • 9. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
    Graff GR, McNamara J, Royall J, Caras S, Forssmann K.
    Clin Drug Investig; 2010 Aug 01; 30(6):351-64. PubMed ID: 20441244
    [Abstract] [Full Text] [Related]

  • 10. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
    Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P.
    Pancreas; 2013 Aug 01; 42(6):983-9. PubMed ID: 23587850
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Knop FK, Vilsbøll T, Lund A, Krarup T, Holst JJ, Hornum M.
    JOP; 2010 Sep 06; 11(5):489-91. PubMed ID: 20818126
    [No Abstract] [Full Text] [Related]

  • 15. A Retrospective Real-World Evidence Evaluation of the Characteristics of Exocrine Pancreatic Insufficiency in Patients With Chronic Pancreatitis and Type 2 Diabetes Treated With Pancrelipase in the United States.
    Rosenberg J, Reddy MN, Seelam P, Li O, Twal J, Pack J.
    Pancreas; 2010 Sep 06; 51(10):1308-1314. PubMed ID: 37099771
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study.
    Kahl S, Schütte K, Glasbrenner B, Mayerle J, Simon P, Henniges F, Sander-Struckmeier S, Lerch MM, Malfertheiner P.
    JOP; 2014 Mar 10; 15(2):165-74. PubMed ID: 24618443
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S.
    J Cyst Fibros; 2009 Dec 10; 8(6):370-7. PubMed ID: 19815466
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC, Strausbaugh SD, Woo MS, Tong SY, Silber SA, Mulberg AE, Leitz G.
    J Cyst Fibros; 2011 Sep 10; 10(5):350-6. PubMed ID: 21632288
    [Abstract] [Full Text] [Related]

  • 20. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S.
    Am J Gastroenterol; 2010 Oct 10; 105(10):2276-86. PubMed ID: 20502447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.